ArticleFrontiers in cardiovascular medicine2022

The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022.

Xia Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.